Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208858 · ClinicalTrials.gov registry record · Phase 2
A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving
A Phase 2 study, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00208858 is a Phase 2 study that has completed, run by Emory University.
The verdict
NCT00208858, a Phase 2 study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
The purpose of this study is to gather pilot data to determine feasibility of and guide the development of a larger clinical trial investigating the effects of topiramate as an adjunct to nicotine replacement therapy and behavioral counseling in smoking cessation treatment. It is hypothesized that topiramate will decrease nicotine craving and result in improved outcomes for smoking cessation.
Interventions
- DRUG Topiramate
Trial Details
| Field | Value |
|---|---|
| Start Date | 2004-12 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208858
The ClinicalTrials.gov registry entry for NCT00208858 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Topiramate is the first listed.
NCT00208858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208858 about?
NCT00208858 is a clinical study titled "A Pilot Study of the Neural Correlates of Treatment Effect on Nicotine Craving". The purpose of this study is to gather pilot data to determine feasibility of and guide the development of a larger clinical trial investigating the effects of topiramate as an adjunct to nicotine replacement therapy and behavioral counseling in smoking cessation treatment. It is hypothesized that t...
What is the current status of trial NCT00208858?
This trial is currently completed. It is a Phase 2 study. The study started on 2004-12. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00208858?
The interventions under investigation include: Topiramate (DRUG).
Who is sponsoring clinical trial NCT00208858?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.